Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -62.8% | -28.0% | 0 / 3 | -5.8% | -2.77 pp | -2.74 pp | +24.4% | 0.00 | 18.35 | 208 | −5,8% | 21,4 | −25,6% | 18.35 | 14.95 | +22,7% |
| Pts | 0 | 0 | 0 | 0 | 4 | 0 | 12 | 12 | 4 | |||||||
Valuation annotation:Price: 87.900 (close price on 2026-10-14)EPS (TTM): 4.791
Financial charts
1.Revenue & growth
VND bn208Q2/26
1.Revenue & growth
VND bn208Q2/26
2.Profit & growth
VND bn21,4Q2/26
3.Profit mix (Penman)
VND bn96,5Q2/26
4.Margins & cost structure
%20.8%Q2/26
5.Returns & cash cycle
% · days48.8%Q2/26
6.Earnings quality & cash
VND bn57,2Q2/26
7.Asset structure
VND bn434Q2/26
8.Funding & debt health
VND bn · times434Q2/26
9.Revenue backlog
VND bn3,41Q2/26
10.Valuation
times · %32,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.374Q2/26
Adjusted EPS growth, latest quarter
-25.6%
Average adjusted EPS growth, 3 quarters
-15.6%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26